Study to Evaluate Effectiveness of Investigational Device in the Assistance of Detection and Diagnosis of Breast Cancer

NCT05615298 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2022-11-14

No results posted yet for this study

Summary

This study aims to evaluate Effectiveness of Investigational Device, Lunit INSIGHT MMG, in the assistance of Detection and Diagnosis of Breast Cancer during Screening Mammography Interpretation.

Conditions

Interventions

RADIATION

Mammography

FFDM (Full-Field Digital mammography)

Sponsors & Collaborators

  • Lunit Inc.

    lead INDUSTRY

Principal Investigators

  • Gregg Miller, MD · Atrius Health

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-15
Primary Completion
2021-01-13
Completion
2021-01-13
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05615298 on ClinicalTrials.gov